In a groundbreaking medical development, researchers at New York University Abu Dhabi (NYUAD) have unveiled a new brain implant capable of delivering drugs to multiple areas of the brain with remarkable precision.
The innovation, known as Strategic Precision Infusion for Regional Administration of Liquid (SPIRAL) could transform how doctors treat complex neurological disorders.
Led by Khalil Ramadi, Assistant Professor of Bioengineering at NYUAD and his team, the device is a thin, flexible tube that releases medication through multiple, carefully spaced points within the brain. This allows for wider and more controlled drug distribution, while keeping the implant minimally invasive and safe.
Ramadi said, "Neurological disorders often come from very specific regions of the brain, but our current tools for targeting these areas are limited. SPIRAL allows us to reach several regions at once without adding extra risk, which could change how we deliver therapy for these conditions".
This breakthrough will offer a crucial advantage in treating neurological disorders like Parkinson’s disease and epilepsy, and even aggressive brain cancers like glioblastoma.